Munich - Delayed Quote EUR

TG Therapeutics Inc (NKB2.MU)

Compare
27.71
+0.20
+(0.75%)
As of 8:02:02 AM GMT+1. Market Open.
Loading Chart for NKB2.MU
DELL
  • Previous Close 27.50
  • Open 27.71
  • Bid 27.48 x --
  • Ask 28.30 x --
  • Day's Range 27.71 - 27.71
  • 52 Week Range 12.34 - 34.14
  • Volume 0
  • Avg. Volume 29
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 26, 2025 - Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: NKB2.MU

View More

Performance Overview: NKB2.MU

Trailing total returns as of 1/13/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

NKB2.MU
12.12%
S&P 500
1.35%

1-Year Return

NKB2.MU
75.44%
S&P 500
21.81%

3-Year Return

NKB2.MU
85.35%
S&P 500
23.29%

5-Year Return

NKB2.MU
32.74%
S&P 500
78.45%

Compare To: NKB2.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NKB2.MU

View More

Valuation Measures

Annual
As of 1/10/2025
  • Market Cap

    4.37B

  • Enterprise Value

    4.28B

  • Trailing P/E

    37.63

  • Forward P/E

    20.75

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    17.04

  • Price/Book (mrq)

    22.94

  • Enterprise Value/Revenue

    16.65

  • Enterprise Value/EBITDA

    757.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: NKB2.MU

View More

Company Insights: NKB2.MU

Research Reports: NKB2.MU

View More